Literature DB >> 27616028

Effects of in-vitro cultured calculus bovis on learning and memory impairments of hyperlipemia vascular dementia rats.

Xiao-Ming Zhong1, Xue-Cong Ren2, Ye-Liang Lou3, Meng-Jing Chen4, Guan-Ze Li5, Xue-Yuan Gong6, Zhen Huang7.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: In-vitro cultured calculus bovis (ICCB) is a quality substitute for natural bezoar which is used for the therapeutic purpose of treating encephalopathy. ICCB has been authorized to use on clinic. The aim of the study is to evaluate the effects and the potential mechanisms of in-vitro cultured calculus bovis (ICCB) on learning and memory impairments of hyperlipemia vascular dementia (HVD) rats.
MATERIALS AND METHODS: The HVD model was established by permanent occlusion of bilateral common carotid arteries based on hyperlipemia rats. Learning and memory abilities were evaluated by morris water maze test and shuttle box test. Ultraviolet-visible spectrophotometry (UV-vis) was employed to determine the SOD, MDA and NO in cerebral tissue, as well as the TG in serum. HE staining and toluidine blue staining were employed to evaluate cone cells damage in hippocampus CA1. An immunohistochemistry was used to measure the Bax and Bcl-2 expressions in cerebral tissue.
RESULTS: Compared with control group, the abilities of spatial learning and memory and conditional memory were decreased significantly in HVD group (P<0.01, P<0.05). MDA content in cerebral tissue was remarkably increased while the SOD activity and NO content were both decreased (P<0.01). TG content in serum was increased remarkably (P<0.01). And the cone cells in hippocampus CA1 were damaged obviously. Compared with HVD group, ICCB treatment improved the abilities of learning and memory, elevated the SOD activity (P<0.01, P<0.05), reduced the MDA content (P<0.01) as well as the TG content in serum (P<0.01), increased the NO content (P<0.01), improved the damaged cone cells in hippocampus CA1, increased the number of cones cells (P<0.01), decreased the Bax expression, and increased the Bcl-2 expression (P<0.01).
CONCLUSION: ICCB could improve the abilities of learning and memory in HVD rats. It might be related to anti-oxidative, regulation of Bax and Bcl-2 expressions, and the alleviation of cone cells damage.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anti-oxidative; Bax; Bcl-2; Hyperlipemia vascular dementia; In-vitro cultured calculus bovis; Learning and memory impairments

Mesh:

Substances:

Year:  2016        PMID: 27616028     DOI: 10.1016/j.jep.2016.09.014

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Hepatoprotective effect of calculus bovis sativus on nonalcoholic fatty liver disease in mice by inhibiting oxidative stress and apoptosis of hepatocytes.

Authors:  Wenxi He; Yanjiao Xu; Chengliang Zhang; Jingli Lu; Juan Li; Dong Xiang; Jinyu Yang; Mujun Chang; Dong Liu
Journal:  Drug Des Devel Ther       Date:  2017-12-05       Impact factor: 4.162

2.  Investigation of the synergistic effects of haloperidol combined with Calculus Bovis Sativus in treating MK-801-induced schizophrenia in rats.

Authors:  Kai Lei; Guo-Fang He; Cheng-Liang Zhang; Ya-Nan Liu; Juan Li; Guang-Zhao He; Xi-Ping Li; Xiu-Hua Ren; Dong Liu
Journal:  Exp Anim       Date:  2017-12-08

3.  Gardenia jasminoides J. Ellis extract GJ-4 attenuates hyperlipidemic vascular dementia in rats via regulating PPAR-γ-mediated microglial polarization.

Authors:  Hui Liu; Caixia Zang; Junmei Shang; Zihong Zhang; Lu Wang; Hanyu Yang; Chanjuan Sheng; Fangyu Yuan; Cheng Ju; Fangyuan Li; Yang Yu; Xinsheng Yao; Xiuqi Bao; Dan Zhang
Journal:  Food Nutr Res       Date:  2022-07-19       Impact factor: 3.221

4.  Synergistic neuroprotective effects of Geniposide and ursodeoxycholic acid in hypoxia-reoxygenation injury in SH-SY5Y cells.

Authors:  Fafeng Cheng; Chongyang Ma; Liangming Sun; Xiaoyu Zhang; Changming Zhai; Changxiang Li; Shuang Zhang; Beida Ren; Shuling Liu; Songnan Liu; Xiangjun Yin; Xueqian Wang; Qingguo Wang
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.